Molecular diagnostic testing for primary biliary cholangitis Gatselis NK, Dalekos GN. Expert Rev Mol Diagn. 2016 Sep;16(9):1001-10. doi: 10.1080/14737159.2016.1217159. Epub 2016 Aug 8.

von Willebrand factor and procoagulant imbalance independently predict outcome in patients with cirrhosis and thrombocytopenia. Kalambokis GN, Oikonomou A, Christou L, Kolaitis NI, Tsianos EV,

Reliability and applicability of two-dimensional shear-wave elastography for the evaluation of liver stiffness. Varbobitis IC, Siakavellas SI, Koutsounas IS, Karagiannakis DS, Ioannidou P, Papageorgiou MV,

Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence? The case of Greece. Gountas I, Sypsa V, Papatheodoridis

Evaluation of neutrophil/leukocyte ratio and organ failure score as predictors of reversibility and survival following an acute-on-chronic liver failure event. Agiasotelli D, Alexopoulou A, Vasilieva

Discontinuation of oral antivirals in chronic hepatitis B: A systematic review. Papatheodoridis G, Vlachogiannakos I, Cholongitas E, Wursthorn K, Thomadakis C, Touloumi G, Petersen J.

Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia. Alexopoulou A, Vasilieva L, Agiasotelli

TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment. Argentou N, Germanidis G, Hytiroglou P,

Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency. Foka P, Dimitriadis A, Karamichali E, Kyratzopoulou E, Giannimaras D,

Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial